San Francisco (January 7, 2021) – Global health innovation leader W2O today announced it has acquired tech-enabled companies Swoop and IPM.ai, further accelerating what is expected to be its 20th consecutive year of double-digit revenue growth.

“The next frontier for the healthcare industry is using value-based and outcomes-driven messaging to connect the right patients to the right treatment at the right time,” said Jim Weiss, Founder and CEO of W2O. “In the increasingly digital post-pandemic era, we need to help our clients move faster and with more precision and efficiency to conduct clinical trials, launch new products, maximize peak revenue opportunities, and successfully navigate product lifecycles. The acquisition of Swoop and IPM.ai enables this game-changing approach – with the goal of improving healthcare from bench to bedside.”

Swoop and IPM.ai are pioneers in using artificial intelligence, and real world data to solve big challenges in healthcare. Swoop creates precise patient audiences, improving targeting of healthcare engagement and empowering patients to become active participants in their treatment journey. IPM.ai uncovers the ideal patient, enabling accelerated research, development, and commercialization of life-saving therapies in under-defined patient populations.

“Joining W2O brings Swoop and IPM.ai access to additional resources, health care expertise and opportunities to fuel our already impressive growth, as we help life sciences companies uncover, activate and ultimately engage their ideal patient populations and health networks,” said Ron Elwell, Founder and CEO of Swoop and IPM.ai. “Our existing leadership team, technologists, data scientists, life sciences experts and digital marketing professionals will continue to serve our customers, while expanding our team and reach over time.”

The Swoop and IPM.ai acquisition is the ninth for W2O since the company announced its partnership with New Mountain Capital in 2019. W2O achieved more than $350 million in revenue in 2020, an increase of 50% from the prior year.

“Our newly established Health Technology Business combines W2O’s robust data and analytics software with the Symplur, Swoop and IPM.ai tech and data assets. For customers, this will provide a powerful combination of tech-enabled strategic services along with DaaS and SaaS solutions, enabling digital transformation across the clinical and commercial ecosystem,” said Adam Cossman, Group President/Managing Partner of W2O’s Health Technology Business. “We have evolved our business and made big bets on tech-enablement over the past few years and this is another milestone in our transformation to becoming a healthcare innovation company. The Swoop and IPM.ai acquisition catapults us further into this space, adding new solutions to meet the accelerated, real-time changes happening in health care.”

“New Mountain has a long-standing focus on improving healthcare through the application of data and technology,” said Matt Holt, Managing Director and President of Private Equity at New Mountain. “We are excited to continue to invest behind the W2O team to achieve this vision and support their accelerated growth plan.”

“We are working closely with W2O to reimagine an industry that is ripe for transformation, as life sciences companies look to digitize how they go-to-market, conduct clinical trials, and engage with patients, clinicians and decision makers,” added Brian Murphy, Director at New Mountain. “The combination of Swoop and IPM.ai with our existing Health Technology Business will significantly supercharge our efforts in this space and deliver innovative new solutions for clients.”

About Swoop
Swoop empowers the world’s leading pharmaceutical brands to better-educate patients about disease states and the therapies that could remedy their conditions, as well as enable them to become active participants in their treatment journey. Swoop’s HIPAA-certified and NAI-accredited system of engagement uncovers unique target audiences for precisely activating patient populations and their healthcare ecosystems through cross-channel marketing strategies. By utilizing artificial intelligence in conjunction with a real world data universe of over 300 million de-identified patient journeys over ten years and 65 billion anonymous consumer interactions, Swoop's patient segments are superior in audience quality, lead to optimal conversion, and drive increased Rx lift.

About IPM.ai
IPM.ai is an Insights as a Service (IaaS) provider that empowers the world’s leading life sciences companies to better understand and improve the lives of patients through the development and commercialization of precision medicine for specialty and rare diseases. IPM.ai’s system of insight streamlines market assessment, patient finding, treatment journey mapping, healthcare provider discovery, key opinion leader identification and brand activation by utilizing granular-level longitudinal analytics, artificial intelligence in conjunction with real-world evidence, social determinants of health, and an outcomes research data universe of over 300 million de-identified patient journeys spanning a decade.

About W2O
Founded by Jim Weiss in 2001 and built on an ethos of entrepreneurship, staying fluid, and doing the right thing, W2O has achieved 19 years of uninterrupted growth while remaining fiercely independent. W2O is an alchemic mix of 1,500 people and hundreds of clients and partners – working from bench to bedside – to make the world a healthier place. Driven by data, W2O applies proprietary analytics and best-in-class technology to build insights that power creative ideas and concepts. W2O seeks to become the partner of choice to empower optimal healthcare knowledge, access and outcomes – now and in the future. For more information, please visit www.w2ogroup.com.